Refine
Has Fulltext
- yes (48)
Is part of the Bibliography
- yes (48)
Year of publication
Document Type
- Journal article (48)
Language
- English (48) (remove)
Keywords
- prostate cancer (7)
- DNA damage (6)
- radiotherapy (6)
- Medizin (5)
- IGRT (3)
- Radiosurgery (3)
- glioblastoma multiforme (3)
- head and neck cancer (3)
- hypofractionation (3)
- long-term outcome (3)
- radiosensitivity (3)
- DNA repair (2)
- DNA-PK (2)
- Glioblastoma (2)
- Halcyon (2)
- Image-guidance (2)
- NSCLC (2)
- NVP-BEZ235 (2)
- PTEN (2)
- Radiotherapy (2)
- Stereotactic body radiotherapy (2)
- Strahlentherapie (2)
- VMAT (2)
- apoptosis (2)
- autophagy (2)
- cell cycle arrest (2)
- cone beam CT (2)
- histone H2AX (2)
- hypoxia (2)
- image-guided radiation therapy (2)
- metastasis-directed therapy (2)
- migration (2)
- oligorecurrence (2)
- osteopontin (2)
- p53 (2)
- radiation sensitivity (2)
- rectal cancer (2)
- salvage radiotherapy (2)
- simultaneous integrated boost (2)
- toxicity (2)
- 3D conformal silicone bolus (1)
- 3D printer (1)
- 4D-MRI (1)
- ATM (1)
- AZD6244 (1)
- Adaptation (1)
- Akt (1)
- Automated analysis (1)
- Brain cancer (1)
- CD133 (1)
- CIED malfunction; pacemaker (PM) (1)
- CNS cancer (1)
- Combination (1)
- Cone-beam CT (1)
- Corticosteroids (1)
- DNA double strand breaks (1)
- DNA double-strand breaks (1)
- DNA repair protraction (1)
- DNS-Reparatur (1)
- DNS-Schädigung (1)
- EBRT (1)
- Extended field irradiation (1)
- Follicular lymphoma (1)
- Frame-based (1)
- Frame-less (1)
- Glioma stem cells (1)
- Head and neck cancer (1)
- High grade glioma (1)
- Histone gamma H2AX (1)
- IMAT (1)
- IMRT (1)
- IR (1)
- ImageJ plugin (1)
- Improved survival (1)
- Inter-observer variability (1)
- Ionizing radiation (1)
- Locoregional recurrence (1)
- Lung cancer (1)
- Meningioma (1)
- N-Myc down regulated gene 1 (1)
- Nestin (1)
- Non-rigid image registration (1)
- Normal tissue tolerance (1)
- Novel PI3K (1)
- Open-source tool (1)
- Osteopontin (1)
- PI3K (1)
- PRRT (1)
- PSMA (1)
- PSMA PET/CT (1)
- Pain (1)
- Pelvic tumors (1)
- Peptide receptor radionuclide therapy (1)
- Peripheral blood lymphocytes (1)
- Phase II trial (1)
- Prostate carcinoma (1)
- Radiation biology (1)
- Radiation sensitivity (1)
- Radiosensitivity (1)
- Radiotherapy treatment planning (1)
- Re-irradiation (1)
- Rectal cancer (1)
- Respiration correlated imaging (1)
- Respiratory induced tumor motion (1)
- Short dsRNA oligonucleotides (1)
- Spinal metastases (1)
- Spinal metastasis (1)
- Step and Shoot IMRT (1)
- Stereotactic (1)
- Synergy (1)
- TGFβ1 (1)
- TME (1)
- Temozolomide (1)
- Total nodal irradiation (1)
- \(\gamma\)h2ax (1)
- acute toxicity (1)
- adaptation (1)
- adaptive radiotherapy (1)
- androgen deprivation therapy (1)
- anxiety (1)
- auto-planning (1)
- battery depletion (1)
- biochemical relapse free survival (1)
- blood lymphocytes (1)
- brain cancer (1)
- cancer (1)
- capacitance (1)
- cardiac implantable electronic devices (CIED) (1)
- cardiac resynchronization therapy (CRT) (1)
- cell membranes (1)
- chemotherapy (1)
- colony survival (1)
- cone-beam ct (1)
- deformable image registration (1)
- depression (1)
- dominant intraprostatic lesion (1)
- dose accumulation (1)
- dose escalation (1)
- dose evaluation (1)
- dose to OARs (1)
- double arc (1)
- external beam radiotherapy (EBRT) (1)
- flat silicone bolus (1)
- foci (1)
- full arc (1)
- fused deposition modeling (FDM) (1)
- gamma H2AX-foci (1)
- guidance (1)
- head (1)
- helical tomotherapy (1)
- high-dose-rate (HDR) brachytherapy (1)
- high-dose-rate brachytherapy boost (1)
- histone γH2AX (1)
- hospital-based palliative care (1)
- human cancer diseases (1)
- hypotonic (1)
- implantable cardioverter defibrillator (ICD) (1)
- in vivo (1)
- individual radiosensitivity (1)
- individual silicone bolus (1)
- intensity-modulated radiation therapy (1)
- irradiation (1)
- irridation (1)
- isotonic (1)
- limitations (1)
- local control (1)
- lung cancer (1)
- lymph node metastases (1)
- mTOR (1)
- mTOR Inhibitor (1)
- macroscopic recurrence (1)
- megavoltage computed-tomography (1)
- membrane characteristics (1)
- membrane proteins (1)
- microvilli (1)
- multimodal therapy (1)
- multiple brain metastases (1)
- neck cancer (1)
- oligmometastases (1)
- optimization (1)
- oral mucositis (1)
- outcomes research (1)
- partial arc (1)
- patient-reported outcome (1)
- perioperative changes (1)
- peripheral blood lymphocytes (1)
- phosphorylation (1)
- plan comparison (1)
- propensity score matching (1)
- prostate Imaging Reporting and Data System (1)
- prostate-cancer (1)
- quaility indicator (1)
- radiation therapy (1)
- radiosensibility (1)
- radiotherapy (RT) (1)
- re-irradiation (1)
- re-planning (1)
- repair (1)
- scanning electron microscopy (1)
- setup verification (1)
- single arc (1)
- stereotactic body radiotherapy (1)
- surface dose measurement (1)
- survival (1)
- therapy (1)
- thoracic cancer (1)
- transperineal ultrasound (1)
- treatment (1)
- treatment plan (1)
- volumetric modulated arc therapy (VMAT) (1)
- whole breast irradiation (1)
- wound healing (1)
Institute
- Klinik und Poliklinik für Strahlentherapie (46)
- Theodor-Boveri-Institut für Biowissenschaften (9)
- Comprehensive Cancer Center Mainfranken (3)
- Klinik und Poliklinik für Nuklearmedizin (3)
- Klinik und Poliklinik für Hals-, Nasen- und Ohrenkrankheiten, plastische und ästhetische Operationen (2)
- Medizinische Klinik und Poliklinik II (2)
- Pathologisches Institut (2)
- Frauenklinik und Poliklinik (1)
- Institut für Geschichte der Medizin (1)
- Institut für Klinische Epidemiologie und Biometrie (1)
Purpose: This study analyses a large number of cancer patients with CIEDs for device malfunction and premature battery depletion by device interrogation after each radiotherapy fraction and compares different guidelines in regard to patient safety. Methods: From 2007 to 2022, a cohort of 255 patients was analyzed for CIED malfunctions via immediate device interrogation after every RT fraction. Results: Out of 324 series of radiotherapy treatments, with a total number of 5742 CIED interrogations, nine device malfunctions (2.8%) occurred. Switching into back-up/safety mode and software errors occurred four times each. Once, automatic read-out could not be performed. The median prescribed cumulative dose at planning target volume (PTV) associated with CIED malfunction was 45.0 Gy (IQR 36.0–64.0 Gy), with a median dose per fraction of 2.31 Gy (IQR 2.0–3.0 Gy). The median maximum dose at the CIED at time of malfunction was 0.3 Gy (IQR 0.0–1.3 Gy). No correlation between CIED malfunction and maximum photon energy (p = 0.07), maximum dose at the CIED (p = 0.59) nor treatment localization (p = 0.41) could be detected. After excluding the nine malfunctions, premature battery depletion was only observed three times (1.2%). Depending on the national guidelines, 1–9 CIED malfunctions in this study would have been detected on the day of occurrence and in none of the cases would patient safety have been compromised. Conclusion: Radiation-induced malfunctions of CIEDs and premature battery depletion are rare. If recommendations of national safety guidelines are followed, only a portion of the malfunctions would be detected directly after occurrence. Nevertheless, patient safety would not be compromised.